SERVICES

WBL Exclusive Genomic & Epigenomic Solutions
Direct Whole Methylome Sequencing (gDNA)Direct Methylation Sequencing (cfDNA)Direct Targeted Methylation Sequencing (gDNA)
Oxford Nanopore Technologies
Custom & Clinical Services
After identifying your targets of interest—through WBL services or other methods—our scientists collaborate with you to develop customized targeting solutions optimized for your project’s goals.
After identifying your targets of interest—through WBL services or other methods—our scientists collaborate with you to develop customized targeting solutions optimized for your project’s goals.
Meet with our team to explore your therapeutic area of interest, establish clear objectives, and determine the optimal approach for your desired endpoints.
Leverage our biomarker discovery services to identify genes, regions, or other genomic features critical to your project.
Utilize hybridization-based enrichment with optimized oligonucleotide probes or bioinformatic targeting to analyze specific regions of interest.
Meet with our team to explore your therapeutic area of interest, establish clear objectives, and determine the optimal approach for your desired endpoints.
WBL offers custom bioinformatic solutions to balance breadth, precision, and efficiency for genomic and methylation panels. Pairing biomarker discovery services with custom bioinformatic pipelines to target regions of interest, WBL’s approach reduces noise and redundancy, delivering high-quality results for methylation and native DNA studies at any scale.
Identifying DNA’s cell or tissue of origin through methylation analysis has significant clinical applications, but its use in diagnostics has been limited by bisulfite sequencing biases and restricted target coverage. WBL’s dMS enables precise tissue-of-origin determination by detecting complex tissue-specific methylation signatures.
DNA from Tissue 1 and Tissue 2 was sequenced with dWMS. Bioinformatic targeting of 8,457 Tissue 1-specific regions allowed accurate identification (Figure 2A, 2B).
Ready to move beyond traditional methods to capture true DNA biology—free from chemical treatments, synthetic artifacts, and amplification bias? Wasatch BioLabs provides tailored technologies to streamline research, enhance data reliability, and support decision-making at every stage.